121 Views | 305 Downloads
oliver.reiser@chemie.uni-regensburg.de
We thank Dr. John Bacsa for the X‐ray structure determination.
We thank Dr. Eric A. Voight and Mark A. Matulenko from AbbVie, and Shane W. Krska and Jaume Balsells‐Padros from Merck for helpful discussions.
Financial support (HMLD) was provided by NSF under the CCI Center for Selective C−H Functionalization (CHE‐1700982) and AbbVie. Financial support (OR) was provided by Elitenetzwerk Bayern (SYNCAT).
Financial support for the development of the catalyst, Rh2(R‐TPPTTL)4 was provided by NIH (GM099142‐05).
Funds to purchase the NMR and X‐ray spectrometers used in these studies were supported by NSF (CHE 1531620 and CHE 1626172).
© 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA.